MorphoSys AG
MPSYFOTCHealthcare
$73.27
+$1.51(+2.10%)
Market Cap$2.8B
P/E Ratio—
52W High$73.27
52W Low$25.56
MorphoSys AG (MPSYF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · MPSYF · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2023-12 | 2022-12 | 2021-12 | 2020-12 | 2019-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.24B | $0.28B | $0.18B | $0.33B | $0.07B |
| Cost of Revenue | $0.06B | $0.05B | $0.03B | $0.01B | $0.01B |
| Gross Profit | $0.18B | $0.23B | $0.15B | $0.32B | $0.06B |
| Gross Margin %(computed) | 75.51% | 82.53% | 82.07% | 97.20% | 83.16% |
| Operating Expenses | |||||
| R&D Expenses | $0.28B | $0.30B | $0.23B | $0.14B | $0.11B |
| G&A Expenses | $0.09B | $0.08B | $0.08B | $0.05B | $0.04B |
| Total Operating Expenses | $0.43B | $0.45B | $0.42B | $0.30B | $0.17B |
| Operating Income | ($0.25B) | ($0.22B) | ($0.51B) | $0.12B | ($0.11B) |
| Operating Margin %(computed) | -105.96% | -79.32% | -283.02% | 36.44% | -146.50% |
| Interest Income | $0.02B | $0.00B | $0.10B | $0.09B | $0.00B |
| Interest Expense | $0.11B | $0.12B | $0.18B | $0.10B | $0.00B |
| Income Before Tax | ($0.19B) | $0.02B | ($0.59B) | $0.02B | ($0.11B) |
| Income Tax Expense | ($0.00B) | $0.17B | ($0.08B) | ($0.08B) | ($0.00B) |
| Net Income | ($0.19B) | ($0.15B) | ($0.51B) | $0.10B | ($0.10B) |
| Net Margin %(computed) | -79.63% | -54.29% | -286.47% | 29.87% | -143.56% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-5.53 | $-4.42 | $-15.40 | $3.01 | $-3.26 |
| Wtd Avg Shares | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B |
| EBITDA | ($0.07B) | $0.14B | ($0.52B) | $0.05B | ($0.10B) |
| EBITDA Margin %(computed) | -29.60% | 51.96% | -286.82% | 15.50% | -138.32% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · EUR · B
Explore more MorphoSys AG data
About MorphoSys AG (MPSYF) Income Statement
MorphoSys AG (MPSYF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2023, MPSYF reported revenue of $0.24B, gross profit of $0.18B (gross margin 75.51%), and net income of ($0.19B) — a net profit margin of -79.63%.
Frequently asked questions
MPSYF · 4 questionsMorphoSys AG (MPSYF) reported revenue of $0.24B for 2023, down 14.4% year-over-year.
MPSYF revenueMPSYF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08